Find and Pitch Jounalists, Get Your Story Covered

Tags: urothelial carcinoma sacituzumab govitecan cisplatin sacituzumab enfortumab vedotin

	Profile	Recent Articles on Subject
1	David Nield Science Alert Freelance tech, science writer. Marple, Manchester, UK Technologysciencewriting	Lung Cancer Is Rising in Non-Smokers, And This Could Be Why - 8 days ago
2	Rachael Robertson MedPage Today Investigations & enterprise writer. Covers ob/gyn. @medpagetoday. NYC via PGH Investigative writinghealthcare	Headlines About Doc Who 'Catches' Patient's Cancer Are Popping Up Again - about 2 months ago
3	Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	New First-Line Option for Advanced ALK-Positive Lung Cancer - 2 months ago Retifanlimab-Chemo Combo Boosts PFS in Advanced Squamous Cell Anal Cancer - 5 months ago Immunotherapy Combo Active in Advanced PD-L1-Negative HNSCC - 8 months ago Novel Therapy Promising for Radiation-Induced Oral Mucositis - 12 months ago Two Pembrolizumab Trials in Head and Neck Cancer Yield Divergent Results - 12 months ago Perioperative Tislelizumab Demonstrates Survival Benefit in NSCLC - about 1 year ago Adding Immunotherapy, Anti-TIGIT in First Line Boosts OS in Esophageal Cancer - about 1 year ago Detecting Ovarian Cancer Early; Allergy Med for NSCLC? Bad News for Anti-TIGIT Drug - about 1 year ago Osimertinib Shows Activity in NSCLC With Uncommon EGFR Mutations - over 1 year ago FDA OKs First Drug for Nasopharyngeal Carcinoma - over 1 year ago Sotorasib's Confirmatory Data in NSCLC Unreliable, Says FDA Panel - over 1 year ago Can ctDNA Guide Radiation Use in Oligometastatic NSCLC? - over 1 year ago Delaying Esophageal Cancer Surgery After Neoadjuvant CRT Fails in Trial - over 1 year ago
4	Katie Adams MedCity News Editor. Exeter, New Hampshire editingjournalism	This Pill-Size Diagnostic Seeks to Prevent Thousands of Esophageal Cancer Deaths - 3 months ago
5	Tara Haelle MedPage Today Sci/health journalist. Feminist. Educator. Photographer. Author. DFW science journalismhealthphotographyteaching	ACG Roundup: Young-Onset Barrett's Esophagus on the Rise - 4 months ago
6	MedPage Today Staff MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	What Cancer Type Was Linked to Pollution? - 4 months ago 'SNL' Alum's Inoperable Cancer; Viral Toddler Checkup; Rocket Fuel Chemical in Food - 6 months ago
7	The Conversation Science Alert Science news. Official account. Australia science news	Throat Cancer Is Becoming an Epidemic, And Oral Sex May Be Why - 4 months ago
8	Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	Advances in the Treatment of Resectable NSCLC: Key Insights From CheckMate 77T, NEOSTAR, and CA209-159 Trials - 5 months ago FDA Approves Tislelizumab-jsgr for Advanced or Metastatic Esophageal Squamous Cell Carcinoma After Prior Chemotherapy - 12 months ago
9	Andrew Joseph STAT News Reporter at STAT. Covers health, medicine in Europe. London, England health reportingmedicine	STAT+: Incyte’s checkpoint inhibitor staves off disease progression in anal cancer trial - 5 months ago STAT+: Results on Novartis prostate cancer therapy could expand its use - over 1 year ago
10	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	Exploratory Analysis Shows Favorable Outcomes for Amivantamab-Lazertinib Treatment in NSCLC - 5 months ago FDA Grants Orphan Drug Designation to PT217 for Neuroendocrine Carcinoma - 6 months ago Study Results Show Low Prevalence of S. Pneumonia Nasopharynx-Oropharynx Colonization - 11 months ago FDA Grants Breakthrough Therapy Designation to NVL-520 for ROS1-Positive NSCLC - 12 months ago Pharmacists May See Patients With NSCLC More Often Than Other Care Team Members - about 1 year ago FDA Approves Repotrectinib for Treatment of ROS1-Positive NSCLC - over 1 year ago

Journalists covering nasopharyngeal carcinoma